세계의 향정신약 시장 보고서(2025년)

Nootropics, also known as smart drugs or cognitive enhancers, refer to substances that aim to enhance memory and cognitive function with a stimulant effect. These substances are utilized to boost brain performance and include caffeine, creatine, vitamins, and minerals. Nootropics are often used to increase memory, improve strength, or enhance other cognitive functions. It's important to note that while they may affect memory, thinking, or other mental functions, they do not treat diseases.

The main types of drugs categorized as nootropics include prescription nootropics and over-the-counter (OTC) nootropics. Prescription nootropics are often utilized to provide stimulant effects and may be prescribed to counteract symptoms associated with medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy. Nootropics are available in various forms, including capsules or tablets, powder, drinks, and others, and are distributed through multiple channels, both online and offline. They find application in memory enhancement, mood and depression treatment, attention and focus improvement, longevity and anti-aging efforts, sleep and recovery promotion, and anxiety treatment.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The nootropics market research report is one of a series of new reports from The Business Research Company that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nootropics market size has grown rapidly in recent years. It will grow from $5.23 billion in 2024 to $5.96 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to aging population, regulatory support, increased research and development, e-commerce expansion, rise in esports.

The nootropics market size is expected to see rapid growth in the next few years. It will grow to $11.22 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to increasing stress and cognitive demands, globalization, rising disposable incomes, rising mental health awareness, expansion of emerging markets. Major trends in the forecast period include natural and plant-based nootropics, digital nootropics, transcranial stimulation devices, sustainable and ethical sourcing, inndustry collaboration.

The forecast of 17.2% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of synthetic neuropeptides and cognitive-enhancing supplements sourced from China and Israel, thereby limiting mental health treatment options and elevating neurology clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising investment in health and wellness is anticipated to drive the growth of the nootropics market in the future. Health and wellness are typically understood as approaches individuals take to achieve mental health and physical well-being. This encompasses a thorough exploration of the health and wellness industry. Nootropics play a significant role in supporting an individual's health and wellness; therefore, as the demand for healthcare and wellness rises, the need for nootropics will also increase. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that healthcare spending rose by 5.6% in nominal terms from 2022 to 2023, a significant increase compared to the 0.9% growth noted in 2022. Hence, the growing expenditure on healthcare and wellness is driving the nootropics market.

The rising incidence of lifestyle diseases is expected to drive the growth of the nootropics market in the future. Lifestyle diseases, commonly referred to as non-communicable diseases (NCDs) or chronic diseases, are a collection of health issues primarily resulting from unhealthy lifestyle choices and behaviors rather than infectious agents. Individuals suffering from lifestyle diseases such as obesity and diabetes often face cognitive decline, stress, and decreased energy levels. Nootropics are utilized to enhance cognitive abilities, manage stress, increase energy, and aid in weight management. For example, in September 2022, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that there were 41 million deaths annually worldwide, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases. This included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rising prevalence of lifestyle diseases is propelling the growth of the nootropics market.

The popularity of vegan nootropics is increasing in the global nootropics market. Leading companies in the nootropics sector are pursuing new organic product innovations to satisfy consumer demand and maintain their market position. For example, in July 2022, BioAdaptives Inc., a US-based producer of natural supplements derived from plants and algae, introduced MindMemory, an advanced nootropic designed to enhance memory, mental focus, and concentration. This new product offers a gradual and smooth effect, unlike coffee, which can cause a sudden surge of adrenaline.

Leading companies in the nootropics market are creating multi-flavored nootropics to appeal to a diverse audience with different tastes and preferences. Multi-flavored nootropics are cognitive-enhancing supplements offered in various flavors to enhance taste appeal. For example, in June 2023, Rollagranola, a UK-based food and beverage company, launched a range of nootropics featuring four unique flavors aimed at addressing both nutritional requirements and taste preferences. This innovative lineup includes Calm, Energize, Body and Soul, and Complete Vegan. Calm is designed to promote relaxation and stress reduction with ingredients like ashwagandha and matcha green tea. Energize features a cappuccino and white chocolate blend to boost focus and energy, incorporating lion's mane, caffeine, and panax ginseng. Body and Soul combines summer berries and walnuts to support physical and mental well-being, using ingredients like creatine, maca, ginkgo, and panax ginseng. Finally, Complete Vegan is a granola specifically designed for vegans, offering essential nutrients, pea protein, and key vitamins to address deficiencies and enhance focus, memory, and mood.

In August 2024, Paradigm Sports, a US-based sports management services provider, formed a partnership with Ten Percent Club. This collaboration aims to educate athletes about the advantages of nootropics for enhancing cognitive performance while broadening product offerings in the sports industry to optimize mental preparation and recovery. The partnership seeks to redefine athlete performance through innovative cognitive support solutions. Ten Percent Club is a UK-based company that sells nootropic-based supplements, including Nootropics.

Major companies operating in the nootropics market include Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC ., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, HVMN Inc., BioAdaptives Inc., Powder City

North America was the largest region in the nootropics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The nootropics market includes revenues earned by entities by modafinil (provigil), adderall, methylphenidate (ritalin), memantine (axura), caffeine, l-theanine, and omega-3 fatty acids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nootropics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nootropics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nootropics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nootropics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Prescription Nootropics; OTC Nootropics
• 2) By Form: Capsules or Tablets; Powder; Drinks; Other Forms
• 3) By Distribution Channel: Offline; Online
• 4) By Application: Memory Enhancement; Mood and Depression; Attention and Focus; Longevity and Anti-aging; Sleep and Recovery; Anxiety
• Subsegments:
• 1) By Prescription Nootropics: Stimulants; Cognitive Enhancers; Other Prescription Nootropics
• 2) By Over-the-Counter (OTC) Nootropics: Natural Nootropics; Synthetic Nootropics; Nootropic Blends
• Companies Mentioned: Accelerated Intelligence Inc.; AlternaScript Inc. Health Via Modern Nutrition Inc.; Mental Mojo LLC.; Peak Nootropics; PureLife Bioscience Co. Ltd.; TruBrain; PepsiCo; Superior Supplement Manufacturing; Equinox Nutraceuticals; Natural Stacks Inc.; Gaia Herbs Farms.; Kimera Koffee LLC.; Onnit Labs LLC.; Reckitt Benckiser Group plc.; OUTLIERS INC.; Teva Pharmaceutical Industries Ltd.; United Pharmacies o; Clarity Nootropics; OptiMind; HVMN Inc.; BioAdaptives Inc.; Powder City
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nootropics Market Characteristics

3. Nootropics Market Trends And Strategies

4. Nootropics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nootropics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nootropics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nootropics Market Growth Rate Analysis
• 5.4. Global Nootropics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nootropics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nootropics Total Addressable Market (TAM)

6. Nootropics Market Segmentation

• 6.1. Global Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Nootropics
• OTC Nootropics
• 6.2. Global Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules or Tablets
• Powder
• Drinks
• Other Forms
• 6.3. Global Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.4. Global Nootropics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Memory Enhancement
• Mood and Depression
• Attention and Focus
• Longevity and Anti-aging
• Sleep and Recovery
• Anxiety
• 6.5. Global Nootropics Market, Sub-Segmentation Of Prescription Nootropics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stimulants
• Cognitive Enhancers
• Other Prescription Nootropics
• 6.6. Global Nootropics Market, Sub-Segmentation Of Over-the-Counter (OTC) Nootropics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Nootropics
• Synthetic Nootropics
• Nootropic Blends

7. Nootropics Market Regional And Country Analysis

• 7.1. Global Nootropics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nootropics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nootropics Market

• 8.1. Asia-Pacific Nootropics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nootropics Market

• 9.1. China Nootropics Market Overview
• 9.2. China Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nootropics Market

• 10.1. India Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nootropics Market

• 11.1. Japan Nootropics Market Overview
• 11.2. Japan Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nootropics Market

• 12.1. Australia Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nootropics Market

• 13.1. Indonesia Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nootropics Market

• 14.1. South Korea Nootropics Market Overview
• 14.2. South Korea Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nootropics Market

• 15.1. Western Europe Nootropics Market Overview
• 15.2. Western Europe Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nootropics Market

• 16.1. UK Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nootropics Market

• 17.1. Germany Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nootropics Market

• 18.1. France Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nootropics Market

• 19.1. Italy Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nootropics Market

• 20.1. Spain Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nootropics Market

• 21.1. Eastern Europe Nootropics Market Overview
• 21.2. Eastern Europe Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nootropics Market

• 22.1. Russia Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nootropics Market

• 23.1. North America Nootropics Market Overview
• 23.2. North America Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nootropics Market

• 24.1. USA Nootropics Market Overview
• 24.2. USA Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nootropics Market

• 25.1. Canada Nootropics Market Overview
• 25.2. Canada Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nootropics Market

• 26.1. South America Nootropics Market Overview
• 26.2. South America Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nootropics Market

• 27.1. Brazil Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nootropics Market

• 28.1. Middle East Nootropics Market Overview
• 28.2. Middle East Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nootropics Market

• 29.1. Africa Nootropics Market Overview
• 29.2. Africa Nootropics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nootropics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nootropics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nootropics Market Competitive Landscape And Company Profiles

• 30.1. Nootropics Market Competitive Landscape
• 30.2. Nootropics Market Company Profiles
  • 30.2.1. Accelerated Intelligence Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AlternaScript Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Health Via Modern Nutrition Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mental Mojo LLC. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Peak Nootropics Overview, Products and Services, Strategy and Financial Analysis

31. Nootropics Market Other Major And Innovative Companies

• 31.1. PureLife Bioscience Co. Ltd.
• 31.2. TruBrain
• 31.3. PepsiCo
• 31.4. Superior Supplement Manufacturing
• 31.5. Equinox Nutraceuticals
• 31.6. Natural Stacks Inc.
• 31.7. Gaia Herbs Farms.
• 31.8. Kimera Koffee LLC.
• 31.9. Onnit Labs LLC .
• 31.10. Reckitt Benckiser Group plc.
• 31.11. OUTLIERS INC.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. United Pharmacies o
• 31.14. Clarity Nootropics
• 31.15. OptiMind

32. Global Nootropics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nootropics Market

34. Recent Developments In The Nootropics Market

35. Nootropics Market High Potential Countries, Segments and Strategies

• 35.1 Nootropics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nootropics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nootropics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer